2016-02-01
2024-04-01
2025-03
95
NCT03256201
University of Oklahoma
University of Oklahoma
INTERVENTIONAL
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes
This is a blinded pilot study in which patients scheduled for pancreaticoduodenectomy for pancreatic or related cancers are randomized to dietary counseling and home exercise at high weekly frequency, either with or without individualized resistance training, in order to determine if such an intervention and research design are feasible in this population. We also aim to determine if physical function or quality of life can be improved with only 2-3 weeks of prehabilitation. This is in preparation for a larger study to determine if resistance improves outcomes.
This initial feasibility and proof of concept study focuses on maximizing pancreatic cancer survivors' fitness and physical function in a brief period, the 2-3 weeks available prior to surgical resection, using a home-based exercise program with all equipment provided, and following nutritional recommendations. Intervention begins when the oncologist determines that the patient is a candidate for pancreaticoduodenectomy, and continues until surgery. Participants in both arms are asked to perform moderate exercise daily, targeting a total of 60 minutes per day by the surgery date, but in bouts as short as a few minutes each, and progressed according to tolerance. Initial prescription is individualized according to the patient's baseline level of exercise and functional status. Patients record their exercise and wear an accelerometer to track activity if willing. All participants receive follow-up phone calls from an exercise specialist for adherence and assistance with progression. The intervention period ends at the time of surgery. In this 'quasi-double blinded' randomized trial, participants are not told the difference between the two exercise interventions, and randomization to the two treatment arms is stratified by baseline functional status, such that patients deemed to be 'borderline' in fitness for surgery are distributed across the groups. Prior chemotherapy exposure is allowed and recorded.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates | Results Reporting Dates | Study Record Updates |
---|---|---|
2017-05-26 | N/A | 2024-08-15 |
2017-08-18 | N/A | 2024-08-16 |
2017-08-21 | N/A | 2024-08 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Supportive Care
Allocation:
Randomized
Interventional Model:
Parallel
Masking:
Single
Arms and Interventions
Participant Group/Arm | Intervention/Treatment |
---|---|
EXPERIMENTAL: Standard Exercise Group Patients receive a single instruction session with a physical therapist, for training in moderate intensity (using Rate of Perceived Exertion) exercise including cardiovascular endurance, flexibility, and AROM of upper and lower body. If no other preferre | BEHAVIORAL: Nutritional Counseling
BEHAVIORAL: Standard Exercise
|
EXPERIMENTAL: Enhanced Exercise Group Patients receive a single instruction session with a physical therapist, for training in moderate intensity (using Rate of Perceived Exertion) exercise including cardiovascular endurance, flexibility, and resistance exercise for upper and lower body. If n | BEHAVIORAL: Nutritional Counseling
BEHAVIORAL: Enhanced Exercise
|
Primary Outcome Measures | Measure Description | Time Frame |
---|---|---|
Accrual | The percentage of eligible patients enrolled | 2 year |
Retention | Retention as the percentage of enrolled patients retained assessment point | 2 year |
Adherence | Adherence will be estimated as percentage of prescribed exercise completed based on exercise diaries and phone calls | 2 year |
Secondary Outcome Measures | Measure Description | Time Frame |
---|---|---|
Quality of Life Assessment | Quality of life will be assessed using Functional Assessment of Cancer Therapy General Scale (FACT-G) during the pre-operative period (V1-V2). Scale is 0-108. The higher the score, the better the score. | Approximately 1-3 days pre-op |
Change in Body Weight | Change in baseline body weight in pounds during the pre-operative period (V1-V2) | Approximately 1-3 days pre-op |
Change in Body Weight | Change in baseline body weight in pounds at second post operative visit | Approximately 1-3 days pre-op |
Physical Performance | Six-Minute Walk Test in meters during the pre-operative period (V1-V2). The Six Minute Walk test will be performed according to American Thoracic Society Guidelines. | Approximately 1-3 days pre-op |
Physical Performance | Gait Speed at usual pace | Approximately 2-4 weeks pre-op |
Physical Performance | Grip Strength . with a Jamar handgrip dynamometer . | Approximately 1-3 days pre-op |
Physical Performance | Sit-to-Stand .Time to 5th Stand will be performed according to the Short Performance Physical Battery. | Approximately 4 months post-op |
Assessment of Symptoms | Functional Assessment of Cancer Therapy - Hepatobiliary (FACT-Hep), at first post-operative visit. | Approximately 4 weeks post-op |
Assessment of Symptoms | Functional Assessment of Anorexia-Cachexia Therapy - FAACT, during the pre-operative period (V1-V2). | Approximately 1-3 days pre-op |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
30 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.